Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype

Renal cancer would greatly benefit from new therapeutic strategies since, in advanced stages, it is refractory to classical chemotherapeutic approaches. In this context, lysosomal protease cysteine cathepsins may represent new pharmacological targets. In renal cancer, they are characterized by a hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudzińska, Magdalena, Parodi, Alessandro, Maslova, Valentina D., Efremov, Yuri M., Gorokhovets, Neonila V., Makarov, Vladimir A., Popkov, Vasily A., Golovin, Andrey V., Zernii, Evgeni Y., Zamyatnin, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281206/
https://www.ncbi.nlm.nih.gov/pubmed/32455715
http://dx.doi.org/10.3390/cancers12051310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281206/
https://www.ncbi.nlm.nih.gov/pubmed/32455715
http://dx.doi.org/10.3390/cancers12051310

Ejemplares similares